ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "education, patient"

  • Abstract Number: 1076 • ACR Convergence 2024

    Assessing the Reliability of ChatGPT on Recombinant Zoster Vaccination for Patients with Rheumatic and Musculoskeletal Diseases

    Akhil Sood, Pegah Jahangiri, Amanda Moyer and Janice Lin, Stanford University, Palo Alto, CA

    Background/Purpose: As artificial intelligence (AI) platforms continue to evolve, large language models (LLMs) such as ChatGPT by OpenAI are increasingly being utilized by patients and…
  • Abstract Number: 1235 • ACR Convergence 2024

    Rheum to Grow: Supporting Young Adults with Childhood-Onset Rheumatic Disease in Their Transition to Adult Care

    Cindy Chiu1, Sadie Van den Bogaerde2, Maya Swaminathan3, Rebecca Sadun4 and Thomason Jenna1, 1University of Washington, Division of Rheumatology, Seattle, WA, 2University of Washington, Seattle, WA, 3MultiCare, Newcastle, WA, 4Duke University, Durham, NC

    Background/Purpose: Transitional care for patients with childhood-onset rheumatic disease is essential, as this transition is known to be a high-risk time for medication nonadherence, lapses…
  • Abstract Number: 1237 • ACR Convergence 2024

    The Art of Choosing Together: Unveiling the Patient’s Perspective in Rheumatology

    ADRIANA VANEGAS1, Guillermo Quiceno2, Luis Lira3, Gina Ochoa4, Álvaro Arbeláez-Cortés5, Mauricio Restrepo-Escobar6 and Virginia Pascual Ramos7, 1HOSPITAL SAN VICENTE FUNDACION - UNIVERSIDAD DE ANTIOQUIA - Asociación Colombiana de Reumatología (ASOREUMA), MEDELLIN, Colombia, 2University of Tennessee Graduate School of Medicine, Dallas, TX, 3Sociedad Chilena de Reumatología, Santiago, Chile, 4Fundación LICAR, Barranquilla, Colombia, 5Clínica IMBANACO, Cali, Colombia, 6Universidad de Antioquia, Retiro, Colombia, 7Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Federal District, Mexico

    Background/Purpose: Scientific evidence supports that shared decision-making (SDM) can improve adherence to treatment, patient satisfaction, quality of life, clinical outcomes, and healthcare costs. However, challenges…
  • Abstract Number: 1241 • ACR Convergence 2024

    Optimizing Communication of Methotrexate (MTX) Side Effects: A Patient-Centered Approach Focused on Learning Styles and Preferred Language

    Veena Patel1, Sophia Dove2 and Veronica Chavez3, 1Dell Medical School - UT Health Austin, Austin, TX, 2Moody College of Communication, The University of Texas at Austin, Austin, TX, 3University of Texas - Dell Medical School, Austin, TX

    Background/Purpose: Methotrexate (MTX) remains the first-line treatment for RA due to its effectiveness and affordability, but communicating its complex regimen and instructions can be challenging,…
  • Abstract Number: 1243 • ACR Convergence 2024

    A Patient-Focused Program for Using Steroids Wisely

    John Stone1, Michelle Petri2, Jeffrey Gelfand3, Camille Kotton4, Jane McDowell5, George Papaliodis6, meredith Marinaro7, Matt Wilkinson8, Walter Lentfert9 and Martha Stone10, 1Massachusetts General Hospital , Harvard Medical School, Concord, MA, 2Johns Hopkins University School of Medicine, Timonium, MD, 3University of California, San Francisco, San Francisco, CA, 4Harvard Medical School, Boston, MA, 5Queens University Belfast, Belfast, Ireland, 6Massachusetts General Hospital, Boston, MA, 7Novartis, Hartford, CT, 8UpThereEverywhere, London, United Kingdom, 9UpThereEverywhere, Wilmington, NC, 10Steritas, LLC, CONCORD, MA

    Background/Purpose: Patients have no comprehensive, curated resource on steroid use to facilitate effective collaboration in their own care. Consequently, truly shared decision making around steroid…
  • Abstract Number: 1256 • ACR Convergence 2024

    Higher Disease Activity in Pediatric Systemic Lupus Erythematosus Is Associated with a Greater Desire for Social Health Education: An Unmet Need in Pediatric Rheumatology

    Kaitlin Kirkpatrick, Melodee Liegl, Ke Yan and Sara Sabbagh, Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: There is limited evidence on the educational needs and preferences of caregivers and adolescents and young adults (AYA) with rheumatic disease (RD) regarding the…
  • Abstract Number: 1320 • ACR Convergence 2024

    Acceptability and Satisfaction of an Online Resilience-Building Intervention with Peer Health Coaches for Managing Fatigue and Well-Being in Systemic Sclerosis

    Susan Murphy1, Yen Chen2, Alexandra Harper2, Nirali Shah2, Mary Alore2, Sheri Hicks2, Adam Pape3 and Dinesh Khanna2, 1University of Michigan, Plymouth, MI, 2University of Michigan, Ann Arbor, MI, 3University of Michigan, University of Michigan, MI

    Background/Purpose: Non-pharmacological fatigue management interventions in systemic sclerosis (SSc) are limited, despite people with SSc reporting that fatigue is inadequately addressed with clinical care. We…
  • Abstract Number: 0350 • ACR Convergence 2024

    Piloting an Adaptation of the Making It Work Program for Systemic Sclerosis: Promising Effects on Job Related Self-efficacy and Risk of Work Disability

    Janet Poole1, Kristine Carandang2, Mary Thelander Hill1, Jessica Salazar1, Anna Koch3, Timothy Dionne1 and Diane Lacaille4, 1University of New Mexico, Albuquerque, NM, 2Young Patients' Autoimmune Research & Empowerment Alliance, San Diego, CA, 3Comfy Couch Counseling LLC, Albuquerque, NM, 4Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Although work disability presents a substantial burden for people with systemic sclerosis (SS), there are no tailored programs that aim to support their employment.…
  • Abstract Number: 1676 • ACR Convergence 2024

    Changing Patients’ Mindsets About Non-Severe Side Effects of Methotrexate: A Randomized Controlled Trial

    Rachael Yielder1, Kari Leibowitz2, Alia Crum2, Paul Manley3, Nicola Dalbeth1 and Keith Petrie4, 1University of Auckland, Auckland, New Zealand, 2Stanford University, Palo Alto, CA, 3Te Whatu Ora Health New Zealand, Auckland, New Zealand, 4The University of Auckland, Auckland, New Zealand

    Background/Purpose: Although methotrexate (MTX) is a first-line treatment for inflammatory rheumatic diseases, side effects can lead to poor adherence and persistence. A novel intervention involves…
  • Abstract Number: 0371 • ACR Convergence 2024

    This Is Caring: Enhancing Patient Education Materials for Individuals with Morphea Through Qualitative Inquiry

    Jennifer Foster1, Robin Higashi2, Priya Sarlashkar1 and Heidi Jacobe1, 1The University of Texas Southwestern Medical Center, Department of Dermatology, Dallas, TX, 22UT Southwestern Medical Center, Peter O’Donnell Jr School of Public Health, Dallas, TX

    Background/Purpose: Patient education materials (PEMs) are essential for conveying disease and treatment information, empowering patients to actively participate in their care. However, PEMs for rare…
  • Abstract Number: 1913 • ACR Convergence 2024

    Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review

    Mrinalini Dey1, Shyam Budhathoki2, Sofia Ramiro3, Kaleb Michaud4, Helen Elwell5, Sam Norton6, Maya H. Buch7, Andrew Cope1, Richard Osborne8, James Galloway9 and Elena Nikiphorou1, 1King's College London, London, United Kingdom, 2Imperial College London, London, United Kingdom, 3Leiden University Medical Center, Bunde, Netherlands, 4University of Nebraska Medical Center, Omaha, NE, 5British Medical Association, London, United Kingdom, 6King's College London, London, England, United Kingdom, 7Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 8Swinburne University of Technology, Swinburne, Australia, 9Centre for Rheumatic Diseases, King's College London, London, United Kingdom

    Background/Purpose: Health literacy (HL) is a key social determinant of health in inflammatory arthritis (IA), including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, as it…
  • Abstract Number: 0372 • ACR Convergence 2024

    Readability Analysis of the American College of Rheumatology Patient Education Material

    Quynh Giao Nguyen, Arianna Moss and Priyanka Iyer, University of California Irvine, Orange, CA

    Background/Purpose: Patient education materials are an important resource to improve health education. According to the American Medical Association (AMA), education materials should not be written above a 6th grade…
  • Abstract Number: 2164 • ACR Convergence 2024

    Boosting Adherence to “Sick Day Rules”: A Quality Improvement Study in Rheumatology Outpatients on Immunosuppressive Medications, Results of Post-intervention Phase

    Merve Aksoy*, Pamela Gonzalez Manrique, Heinrich-Karl Greenblatt and Katarzyna Gilek-Seibert, Roger Williams Medical Center, Providence, RI

    Background/Purpose: Acute infections are common among rheumatology outpatients receiving immunosuppressive medications (IS). Expert guidance advises pausing IS during acute infection, resuming only when clinically improved,…
  • Abstract Number: 2023 • ACR Convergence 2023

    Transition Readiness over Time in a Rheumatology Transition Clinic

    Background/Purpose: In 2018 we designed a Rheumatology Transition clinic to care for adolescent patients with autoimmune disease. We incorporate Health Care Transition curriculum (HCT) into…
  • Abstract Number: 2026 • ACR Convergence 2023

    Developing a Guided Joint Self-Exam for Rheumatoid Arthritis Patients to Use in Telehealth-Delivered Care

    Kelly Gavigan1, David Curtis2, Jeffrey Curtis3, W. Benjamin Nowell4, Danielle Ali5, Neelkamal Soares6, John Cush7, Rebecca Grainger8, Manas Jinka9, Sandeep Sodhi10, Natalie Fortune9 and Swamy Venuturupalli9, 1Global Healthy Living Foundation, Upper Nyack, NY, 2Global Healthy Living Foundation, San Francisco, CA, 3University of Alabama at Birmingham, Birmingham, AL, 4Global Healthy Living Foundation, Nyack, NY, 5Global Healthy Living Foundation, Upper Nayack, NY, 6Western Mich Univ Homer Stryker MD Sch of Medicine, Kalamazoo, MI, 7University of Texas Southwestern Medical School, Dallas, TX, 8University of Otago, Wellington, New Zealand, 9Attune Health, Beverly Hills, CA, 10Illumination Health, Hoover, AL

    Background/Purpose: Telehealth services and, increasingly, remote therapeutic monitoring, can be used to enable the continuum of clinical care in out-of-office settings. This remotely provided care…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology